After numerous complaints and thousands of lawsuits related to their recalled Rejuvenate and ABG II hip replacements, Stryker Corp. recently agreed to over a $1 billion settlement. The hip implants were recalled in 2012 after patients reported complications from the metal debris inside the devices, in addition to pain and swelling near the implant site. The company advertised that their products were reliable for years, but many devices failed less than two years after being implanted, according to patient reports.
For patients who have already had the hip replacement surgically removed, the base settlement for cases is $300,000. In order to qualify for the settlement, patients must show proof that their defective implant was removed before November 3, 2014. Patients who suffered severe injuries as a result of the hip replacement may qualify for a larger settlement. The deadline to submit a claim is March 2, 2015 and Stryker hopes to pay out claims by the end of 2015.
The hip replacements debuted with the Rejuvenate system in 2009 and the ABG II system in 2010. Stryker did not complete any rigorous clinical testing on either system regarding long-term effectiveness or safety before putting the devices on the market. The company issued a safety alert on both devices in 2012, noting the following possible problems: pain and implant loosening leading to revision surgery, dissolution of the bone, the release of metal ions into the blood stream or body tissue, or premature tissue death.
Stryker hip implants were impacted by serious design flaws that caused pain and complication in patients, especially in situations where the hip implant metal debris broke loose and floated elsewhere in the patient’s body. The company was also accused of not warning patients about the potential risks of having the product implanted, leading many patients to suffer without adequate upfront knowledge about the possible danger. Many patients experienced degradation or fracturing of the modular neck inside the devices.
Over 4,000 lawsuits were filed against the hip implant manufacturer and consolidated into multi-district litigation. The company chose to pursue a settlement offer of more than $1 billion rather than heading to court, perceiving the potential losses from litigation to be even higher.
Our firm is still reviewing cases on behalf of people who received the recalled Stryker hip replacements. We have offices in Atlanta, Georgia and handle cases throughout the country. Call for a free consultation.